In addition to the demand for COVID-19 shots outstripping supply, vaccine manufacturers are struggling to secure supplies of giant plastic bags used in bioreactors that mix pharmaceutical ingredients, thus creating a bottleneck, resulting in more delays of vaccine rollout, the Financial Times reports… MilliporeSigma, a division of Germany’s Merck & Co., said that it had … Continued
The Sharon S. Richardson Community Hospice received a donation of over 10,000 masks from MilliporeSigma last month. Said Dawn Weidemann, site training coordinator for MilliporeSigma: “As part of MilliporeSigma’s COVID-19 efforts in our community, we were able to donate FDA-certified medical-grade masks. Sharon S. Richardson Community Hospice is a local health care organization that is … Continued
MilliporeSigma today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). The deal strengthens MilliporeSigma’s capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments and diagnostics applicable in Covid-19 and many other diseases.
The Pandemic Response CoLab is a joint project by the MIT Center for Collective Intelligence (CCI), MIT Media Lab’s Community Biotechnology Initiative, and founding member MilliporeSigma. The project is an open, online collaboration platform that invites anyone, from individuals to groups, from communities to businesses, to develop actionable solutions for challenges presented by the Covid-19 … Continued
MilliporeSigma today announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, for the development, scale-up and commercial production of Mammoth’s CRISPR-based SARS CoV-2 diagnostic test.
MilliporeSigma today announced the donation of research instruments and materials worth IDR 1.2 billion to support the efforts of Eijkman Institute for Molecular Biology, Indonesia, in its efforts to accelerate vaccine development research. The institute is developing a Covid-19 vaccine based on a local virus strain, in collaboration with several local research institutions.
MilliporeSigma is in the process of adding 160 jobs at its Jaffrey facility as the global life sciences company ramps up production of components used to develop potential Covid-19 treatments and vaccines. The Jaffrey facility primarily makes filtration devices that are used to produce biopharmaceuticals, such as immunotherapies for cancer treatment. These sorts of products … Continued
For companies like MilliporeSigma in Jaffrey and Microspec Corp. in Peterborough, whose products are manufactured for different sectors of the medical field, the onset of the coronavirus pandemic has greatly shifted the ways of doing business. Karen Tiano, company spokesperson for MilliporeSigma, said the company has seen an increased demand for products that are used to … Continued
MIT’s new Pandemic Response CoLab—a joint project of the MIT Center for Collective Intelligence (CCI), the MIT Community Biotechnology Initiative (CBI) at the MIT Media Lab, and MilliporeSigma, as a founding member — has launched today with the goal of bringing together innovators from across the globe to work on solving problems created by the … Continued
Using key learnings from their ongoing collaboration on a schistosomiasis vaccine, MilliporeSigma, along with researchers at Baylor College of Medicine and the Texas Children’s Hospital Center for Vaccine Development, is optimizing the production process to advance two Covid-19 vaccine candidates.